IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding IGM Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 93 | 1 | 82 | −10 |
| Shares | 17.7M | 108 | 18.0M | +289.0K (+1.6%) |
| Value | $402.0M | $2.00K | $305.8M | −$96.2M (−23.9%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held IGM Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 50,000 | $850.5K | 0.09% |
| Endurant Capital Management LP | 30,320 | $515.7K | 0.21% |
| Schroder Investment Management Group | 26,833 | $456.4K | 0.00% |
| Aquatic Capital Management LLC | 2,500 | $42.0K | 0.00% |
| Rockefeller Capital Management L.P. | 160 | $2.00K | 0.00% |
| Nisa Investment Advisors, LLC | 24 | $0 | 0.00% |
Sold out (16)
Institutions that held IGM Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 586,663 | $13.3M |
| Voloridge Investment Management, LLC | 38,914 | $885.0K |
| Jump Financial, LLC | 26,900 | $612.0K |
| Cubist Systematic Strategies, LLC | 19,801 | $450.0K |
| State Board of Administration of Florida Retirement System | 14,748 | $335.0K |
| BNP Paribas Arbitrage, SA | 11,645 | $264.8K |
| Delphia (USA) Inc. | 10,185 | $232.0K |
| Corton Capital Inc. | 9,999 | $227.0K |
| State of Wisconsin Investment Board | 9,388 | $213.0K |
| Two Sigma Investments, LP | 9,281 | $211.0K |
| SG Americas Securities, LLC | 6,322 | $144.0K |
| Quantbot Technologies LP | 3,600 | $81.0K |
| Ensign Peak Advisors, Inc | 1,890 | $43.0K |
| Macquarie Group Ltd | 0 | $13.0K |
| PFS Partners, LLC | 230 | $5.23K |
| Point72 Hong Kong Ltd | 238 | $5.00K |
Not filed for Q4 2022 yet (1)
Institutions that held IGM Biosciences, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 108 | $2.00K |